[AKRO] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[AKRO] Akero Therapeutics, Inc.
Announcement Date
13-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -91.74%
YoY- -78.52%
Quarter Report
AKRO's Result
AKRO's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -26,029 -32,424 -24,330 -28,933 -15,090 -29,711 -21,403 13.94%
Tax -22 -11 -51 -50 -50 -11 -6 137.97%
NP -26,007 -32,424 -24,330 -28,933 -15,090 -29,711 -21,403 13.88%
Tax Rate - - - - - - - -
Total Cost 26,007 32,424 24,330 28,933 15,090 29,711 21,403 13.88%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -0.74 -0.93 -0.70 -0.83 -0.43 -0.86 -0.63 11.33%
EPS Diluted -0.74 -0.93 -0.70 -0.83 -0.43 -0.86 -0.63 11.33%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.